The Canadian Medical Isotope Ecosystem Development Fund (CMIEDF) invests in Canadian programs that advance medical isotope supply or develop emerging technologies in radiotherapeutics and diagnostics.
The Canadian Medical Isotope Ecosystem (CMIE) is pleased to announce the results of its second call for proposals. Three outstanding medical isotope programs have been selected to receive a total of $1.48M in funding. This funding represents a significant investment in the growth and innovation of Canada’s medical isotope sector, and was provided with support from Innovation, Science and Economic Development Canada‘s (ISED) Strategic Innovation Fund (SIF).
The three selected programs are:
- The Canadian Shield – Promation (Ontario)
- Miniaturized synthesis platform for the precise synthesis of radioimmunoconjugates (RICs) using microfluidics – RadioSyn (Ontario)
- The Canadian Production of Barium [14C]Carbonate – RC14 (Quebec)
These programs represent a dynamic step forward in advancing Canada’s ability to produce, develop, and supply medical isotopes, radiopharmaceutical, and other essential technologies. With a growing demand for medical isotopes worldwide, these initiatives will not only drive innovation in Canada’s medical isotope ecosystem but also elevate Canada’s profile as a key global supplier of highly desired isotopes.
By supporting these programs, CMIE is ensuring that Canada remains at the forefront of the global medical isotope market, which plays a crucial role in diagnosing and treating a wide range of medical conditions, including cancer, neurological, and cardiovascular diseases.
CMIE is excited to see these programs grow and thrive as they help address global healthcare needs, positioning Canada as a trusted and innovative leader in the medical isotope space.
In the coming weeks, CMIE will shine a spotlight on each of the funded programs with detailed updates on the CMIE website and LinkedIn, providing insights into the groundbreaking work being undertaken across the country.
For more information about CMIE and its initiatives, please visit cmie.ca, or contact info@cmie.ca
About CMIE
CMIE is an initiative created to accelerate R&D investment, collaboration, technology adoption and training to enable Canada to lead in the innovation of medical isotopes. Through a unique combination of co-investment, cross-industry collaboration, and IP development, we are building a strong medical isotope innovation ecosystem.
We bring together a community of Canadians from industry, academia, and government to advance medical isotopes.